Fidia Farmaceutici S.p.A.

Fidia Farmaceutici S.p.A. manufactures hyaluronic acid-based healthcare products and develops therapeutic solutions for joint care, eye care, specialty care, skin care, and health and wellness. Its work in regenerative medicine draws on the regenerative potential of hyaluronic acid, a field the group has pursued since the 1950s. The portfolio includes ophthalmic medicines, supplements, and medical devices, as well as anti-inflammatory drugs, gynaecological medicinal products, and nutritional supplements. Its focus areas address movement, skin health, sight, and other healthcare needs across international markets.

Established in 1946, the Italian multinational operates as a fully integrated company, managing research and development, production-chain coordination, manufacturing, marketing, and sales. It holds more than 1,500 patents, including more than 1,250 related to hyaluronic acid. The group has more than 1,700 employees and operates through 17 worldwide affiliates and more than 100 local distributors, with a presence in over 120 countries. Recent acquisitions have expanded its ophthalmology, anti-inflammatory, gynaecology, dermatology, urology, medical-device, pharmaceutical, and cosmetics activities, while partnerships support market distribution of ophthalmological medicinal products.